• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Immunis, Inc.

Monday, June 03, 2024
CP
Cell and Gene Therapy and Genome Editing
Immunis is a private biotechnology company researching and developing secretome products to address age-driven immune dysfunction. Our investigational secretome product, IMMUNA, leverages our leading-edge capabilities in cell culture to deliver a product of all natural, all human immune modulators in their natural relative concentrations. Immunis is currently testing the effects of IMMUNA in a Phase 1/2a clinical trial for muscle atrophy.
Immunis, Inc.
Company Website: http://www.immunisbiomedical.com
Lead Product in Development: IMMUNA (formerly known as IMM01-STEM)
Number Of Unlicensed Products (For Which You Are Seeking Partners): 1

Website

http://www.immunisbiomedical.com

Company HQ City

Irvine

Company HQ State

CA

Company HQ Country

United States

CEO/Top Company Official

Hans Keirstead, PhD

Lead Product in Development

IMMUNA (formerly known as IMM01-STEM)

Development Phase of Primary Product

Phase I
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS